Skip to main content
Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
11.14
+0.47 (4.40%)
Mar 9, 2026, 3:34 PM EDT - Market open

Phathom Pharmaceuticals Revenue

In the year 2025, Phathom Pharmaceuticals had annual revenue of $175.11M with 216.93% growth. Phathom Pharmaceuticals had revenue of $57.58M in the quarter ending December 31, 2025, with 94.12% growth.

Revenue (ttm)
$175.11M
Revenue Growth
+216.93%
P/S Ratio
4.97
Revenue / Employee
$471,995
Employees
371
Market Cap
877.82M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025175.11M119.86M216.93%
Dec 31, 202455.25M54.57M8,001.47%
Dec 31, 2023682.00K--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
MannKind 348.97M
Arvinas 262.60M
Xencor 125.58M
Arbutus Biopharma 14.61M
Evommune 13.00M
Janux Therapeutics 10.00M
KalVista Pharmaceuticals 1.43M
Revenue Rankings

PHAT News

More News